Allergan, Merz's $54.4M Nameda Pay-For-Delay Deal Wins OK
A New York federal judge on Monday granted preliminary approval to consumers' $54.4 million settlement with pharmaceutical companies Allergan and Merz over alleged pay-for-delay deals that kept generic versions of the...To view the full article, register now.
Already a subscriber? Click here to view full article